- UK
- How we work
- J&J is at NHS Confed Expo 2026
NHS Confed Expo 2026
At Johnson & Johnson we see ourselves first and foremost as a long-term partner to the NHS, and we are looking forward to attending NHS Confed Expo 2026 at a time of significant health system reform.
We are sponsoring three key sessions featuring leading voices from industry and government to explore how together, we can deliver for patients, the NHS, and the UK life sciences sector.
We are sponsoring three key sessions featuring leading voices from industry and government to explore how together, we can deliver for patients, the NHS, and the UK life sciences sector.
Explore session details
J&J’s NHS Confed Expo sessions take place between 10-11 June at Manchester Central. Explore details below:
From intent to action: creating a compelling case for change in the NHS
Closed round-table session: Weds 10th June, 13:30-14:30pm
The NHS is clear on the need to transform models of care to secure sustainable, high‑quality services for patients. Yet too often, promising ideas struggle to progress from concept to implementation. What separates initiatives that gain traction from those that stall?
This closed-door roundtable will explore what it takes to create a strong ‘case for change’ in the NHS, drawing on insights from transformation leaders and peer-to-peer discussions. The session will also cover how industry and the NHS can partner together to drive change, including an overview of how J&J can support NHS services.
The NHS is clear on the need to transform models of care to secure sustainable, high‑quality services for patients. Yet too often, promising ideas struggle to progress from concept to implementation. What separates initiatives that gain traction from those that stall?
This closed-door roundtable will explore what it takes to create a strong ‘case for change’ in the NHS, drawing on insights from transformation leaders and peer-to-peer discussions. The session will also cover how industry and the NHS can partner together to drive change, including an overview of how J&J can support NHS services.
Should UK patients expect to receive innovative treatments on the NHS?
Panel session: Thurs 11th June, 10:00-10:40am
As pressures on the NHS continue to intensify, should patients still expect timely access to the latest innovative treatments, or is that promise becoming harder to keep?
This panel of strategic, system leaders will explore what enables equitable and timely access to innovation, what trade offs stand in the way, and how the NHS, industry and patients can work differently to ensure innovation delivers for the UK population.
As pressures on the NHS continue to intensify, should patients still expect timely access to the latest innovative treatments, or is that promise becoming harder to keep?
This panel of strategic, system leaders will explore what enables equitable and timely access to innovation, what trade offs stand in the way, and how the NHS, industry and patients can work differently to ensure innovation delivers for the UK population.
Driving the future of cancer care: Professor Dame Sue Hill in conversation with Johnson & Johnson
Fireside chat: Thurs 11th June, 12:00-12:20pm
Dr John Fleming, UK Country Medical Director, Johnson & Johnson and Professor Dame Sue Hill, Chief Scientific Officer for NHS England, explore what the National Cancer Plan means in practice: where progress is being made, where barriers remain, and how national to neighbourhood leadership alongside partners must respond to rising demand, constrained capacity and rapid innovation.
Dr John Fleming, UK Country Medical Director, Johnson & Johnson and Professor Dame Sue Hill, Chief Scientific Officer for NHS England, explore what the National Cancer Plan means in practice: where progress is being made, where barriers remain, and how national to neighbourhood leadership alongside partners must respond to rising demand, constrained capacity and rapid innovation.
Partner with us
We are proud to have partnered with the NHS since its inception and are committed to working collaboratively to develop solutions that make a meaningful difference.
If you are interested in accelerating innovation or transforming the patient experience in partnership with J&J then please get in touch.
If you are interested in accelerating innovation or transforming the patient experience in partnership with J&J then please get in touch.
